Comparison of the Minimum Inhibitory and Mutant Prevention Drug Concentrations for Pradofloxacin and 7 Other Antimicrobial Agents Tested Against Swine Isolates of <i>Actinobacillus pleuropneumoniae</i> and <i>Pasteurella multocida</i>
Pradofloxacin is a dual targeting, bactericidal fluoroquinolone recently approved for treating bacteria causing swine respiratory disease. Currently, an abundance of in vitro data does not exist for pradofloxacin. We determined the minimum inhibitory concentration (MIC) and mutant prevention concent...
Saved in:
| Main Authors: | Joseph M. Blondeau, Shantelle D. Fitch |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/29/22/5448 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment and application of dual rpa-basic and rpa-lfd detection method for pasteurella multocida and actinobacillus pleuropneumoniae
by: Jingjing LI, et al.
Published: (2024-12-01) -
Exogenous L-Serine Alleviates <i>Pasteurella multocida</i>-Induced Inflammation by Reprogramming the Transcription and Metabolism of Macrophages
by: Fang He, et al.
Published: (2025-03-01) -
The Challenge of Developing a Test to Differentiate <i>Actinobacillus pleuropneumoniae</i> Serotypes 9 and 11
by: José Luis Arnal Bernal, et al.
Published: (2025-01-01) -
Health–Economic Impact Attributable to Occurrence of Pleurisy and Pneumonia Lesions in Finishing Pigs
by: Clarisse S. Malcher, et al.
Published: (2024-12-01) -
Evaluating the Immunogenic Potential of ApxI and ApxII from <i>Actinobacillus pleuropneumoniae</i>: An Immunoinformatics-Driven Study on mRNA Candidates
by: Yi Deng, et al.
Published: (2025-04-01)